Page 69 - Read Online
P. 69

Aguiar. Rare Dis Orphan Drugs J 2024;3:13  https://dx.doi.org/10.20517/rdodj.2023.56  Page 13 of 29

               equation to estimate GFR in adults with FD [167,168] . However, given that measured GFR by iohexol plasma
               clearance and isotopic methods is more accurate, depending on local availability, the precise measurement
               of the GFR is recommended for FD patients if the estimated GFR is > 60 mL/min/1.73 m 2[168] .


                                                                            [169]
               Cystatin C was proposed as a reliable marker of renal function [Table 4] . Cystatin C has been compared
               with creatinine in the evaluation of renal function in a cohort of patients treated with agalsidase α for 4
               years, with no significant change in creatinine or in creatinine-based estimated GFR, but with a significant
               increase (just after only one year of ERT) in cystatin C and a concurrent decrease in estimated GFR by Hoek
                       [170]
               equation  (using cystatin C values). The authors concluded that cystatin C was an early marker for the
               decline of GFR, but no gold standard precise measurement of GFR was used to support this conclusion .
                                                                                                      [171]
                                                              [92]
               This finding was further corroborated by another study .
               Cystatin C-based estimation of GFR was compared with measured GFR in a relatively small validation study
               (including several cystatin and creatinine-based equations). In contrast to that previously mentioned, Hoek
               equation was less accurate than CKD-EPI creatinine2009  equation in detecting GFR decline during ERT, but
               Stevens’  equation   (a  creatinine  and  cystatin  C-based  formula)  was  the  one  that  most  closely
                               [172]
               approximated the measured GFR . However, Stevens’ equation development was based on serum cystatin
                                           [173]
               C assays in adults that were not traceable to standard reference material. Consequently, it is no longer
                                                                            [167]
               recommended by international chronic kidney disease (CKD) guidelines .
               Albuminuria/proteinuria
               Role in the identification of preclinical involvement
               Total urinary protein and albumin excretion can be considered important biomarkers in FD nephropathy
               [Table 4]. Proteinuria  (>  150  mg/day)  and  albuminuria  A2  are  usually  the  first  signs  of  renal
               involvement [174-177] . The sensitivity of albuminuria seems superior to that of total urinary protein excretion in
               detecting early renal involvement in FD . Thus, albuminuria remains the best existing marker to detect
                                                  [178]
               early renal involvement, but the relevance of albuminuria A2 as a biomarker is largely based on validation
               studies in the earlier stages of other nephropathy models. Moreover, in FD, nephropathy albuminuria may
               result not only from glomerular damage of the filtration barrier, but also from tubular involvement with
               decreased reabsorption of filtered albumin.


               However, the usefulness of albuminuria and/or proteinuria in identifying incipient FD nephropathy is
               questionable. Although there is a significant correlation between urinary protein excretion rates and foot
                                                                              [16]
               process width and fractional volume of Gb3 inclusions in the podocytes , FD nephropathy is clinically
               silent for a long period and significant histological changes (including nonspecific degenerative lesions) may
               occur without pathological albuminuria and/or proteinuria [15-20] . In incipient stages of FD nephropathy,
               tubular reabsorption of albumin may overcome its increased excretion, limiting the sensitivity of this
               biomarker.

               Prognostic value and role in the evaluation of treatment response
               Furthermore, proteinuria also seems to play an important role in FD nephropathy progression, even in
               patients treated with ERT, because it is an independent risk factor affecting the extent of renal decline and is
               one of the determinants of the success of ERT [12,178-185] . For both genders, the proportion of patients with
               overt proteinuria (> 300 mg/day) and its magnitude and the prevalence of nephrotic range proteinuria are
               higher with more advanced CKD stages [12,178] . Moreover, comparing the GFR decline stratified by baseline
               proteinuria, higher baseline proteinuria levels were associated with more rapid GFR decline, but the patients
               with higher baseline proteinuria were also older and with lower baseline GFR [12,179] . Notwithstanding this, in
   64   65   66   67   68   69   70   71   72   73   74